N-(7-(Methylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide, 95.0%, 5g

DL-alpha-Methoxyphenylacetic Acid>98.0%(GC)(T)5g

Propylene glycol monoethyl ether, min 99%, for synthesis, 5L, plastic packaging.

3-Oxo-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-ethyl ester, 95.0%, 10g

Ethyl 3-Ethoxyacrylate (cis- and trans- mixture)>98.0%(GC)25mL

3-chloro-4-acetamidobenzene-1-sulfonyl chloride, 95.0%, 5g

7-Bromoimidazo[1,2-a]pyridine-3-carboxylic acid, 95.0%, 5g

3-Bromo-5-(trifluoromethyl) pyridine-2-amine, 98.0%, 1g

2-Bromo-5-hydroxybenzonitrile, 98.0%, 250mg

(5-BROMO-2-CHLOROPYRIDIN-4-YL)METHANOL, 95.0%, 5g

2-Cyclohexen-1-ol>95.0%(GC)25mL

4-Fluoro-2,6-dimethylbenzoic acid, 97.0%, 1g

2-Methoxypyridine-3-sulfonyl chloride, 97%, 5g